Screener
Mesa Laboratories MLAB Ratios & Valuation
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×— | 0.6×— | 0.6×— | |
| Liquidity | ||||||
| Current ratio | 1.8×+1.1× | 1.7×+1.1× | 1.9×+1.3× | 2×+1.3× | 0.7×-1.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×-0.6× | 0.4×-0.6× | 0.4×-0.7× | 0.4×-0.7× | 1×+0.5× | |
| Valuation | ||||||
| Market capitalization | $574.42M+72.6% | $488.5M-24.2% | $433.5M-39.5% | $368.65M-47.4% | $537.85M+14.9% | |
| Price / sales | 2.3×+0.9× | 2×-0.7× | 1.8×-1.3× | 1.5×-1.6× | 2.2×+0.1× | |
| Price / book | 3×+1.1× | 2.6×-1.4× | 2.3×-2.3× | 2.1×-2.3× | 3.1×0.0× | |
| Dividend yield | 0.6%-0.4pp | 0.7%+0.2pp | 0.8%+0.3pp | 0.9%+0.5pp | 0.6%-0.1pp |
FAQ
- What are Mesa Laboratories's profit margins?
- Mesa Laboratories (MLAB) runs a 56.8% gross margin and a 2.3% operating margin, with a 1.5% net margin.
- Where do Mesa Laboratories's ratios come from?
- Every ratio is computed from Mesa Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
